Author

Christopher J. Longo

Observed names: C. J. Longo, C. Longo, C.J. LONGO, C.J. Longo, Christopher J Longo, Christopher Longo, Longo, Christopher, Longo, Christopher J.

Institution: McMaster University

Observed institutions: Sunnybrook Health Science Centre, University of Ottawa, University of Toronto, Juravinski Cancer Centre, Kingston General Hospital, London Health Sciences Centre, Canadian Centre for Applied Research in Cancer Control, Eli Lilly (Canada), Cross Cancer Institute, Université de Montréal, McMaster University

ORCID: 0000-0002-3801-485X

Observed ORCID: 0000-0002-3801-485X

OpenAlex ID: A5031523768

Financial and family burden associated with cancer treatment in Ontario, Canada

2006 · Christopher J. Longo, Margaret Fitch, et al. · Supportive Care in Cancer · 216

A prospective, observational registry of patients with severe sepsis: The Canadian Sepsis Treatment and Response Registry*

2008 · Claudio M. Martin, Fran Priestap, et al. · Critical Care Medicine · 189

How do business model and health technology design influence each other? Insights from a longitudinal case study of three academic spin-offs

2014 · P. Lehoux, G. Daudelin, et al. · Research Policy · 132

Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review

2020 · Christopher J. Longo, Margaret I. Fitch, et al. · Supportive Care in Cancer · 131

An examination of cancer patients’ monthly ‘out-of-pocket’ costs in Ontario, Canada

2007 · C.J. LONGO, R. DEBER, et al. · European Journal of Cancer Care · 102

PDF

Effectiveness of Health System Services and Programs for Youth to Adult Transitions in Mental Health Care: A Systematic Review of Academic Literature

2015 · Mark G. Embrett, Glen E. Randall, et al. · Administration and Policy in Mental Health and Mental Health Services Research · 82

Economic guidelines for oncology products: Adaptation of the Canadian Agency for Drugs and Technologies in Health (CADTH) technology assessment guidance document

2009 · N. Mittmann, W. K. Evans, et al. · Journal of Clinical Oncology · 80

Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis

2016 · Nigar Sekercioglu, Lehana Thabane, et al. · PLoS ONE · 77

Experiencing financial toxicity associated with cancer in publicly funded healthcare systems: a systematic review of qualitative studies

2021 · Margaret I. Fitch, Linda Sharp, et al. · Journal of Cancer Survivorship · 73

Patient and family financial burden associated with cancer treatment in Canada: a national study

2021 · Christopher J. Longo, Margaret I. Fitch, et al. · Supportive Care in Cancer · 72

PDF

A Comparative Analysis of Monthly Out-of-Pocket Costs for Patients with Breast Cancer as Compared with Other Common Cancers in Ontario, Canada

2011 · Christopher J. Longo, B. G. Bereza · Current Oncology · 56

PDF

A scoping review of evaluated interventions addressing developmental transitions for youth with mental health disorders

2015 · B. Di Rezze, T. Nguyen, et al. · Child Care Health and Development · 41

Patient characteristics and costs of severe sepsis and septic shock in Quebec

2002 · Jacques Letarte, Christopher J. Longo, et al. · Journal of Critical Care · 39

Emerging Understanding About the Impact of Financial Toxicity Related to Cancer: Canadian Perspectives

2021 · Margaret I. Fitch, Christopher J. Longo · Seminars in Oncology Nursing · 35

Estimating the National Wage Loss from Cancer in Canada

2010 · R.B. Hopkins, R. Goeree, et al. · Current Oncology · 33

PDF

The association of cancer-related fatigue on the social, vocational and healthcare-related dimensions of cancer survivorship

2023 · Jennifer M. Jones, Doris Howell, et al. · Journal of Cancer Survivorship · 32

PDF

Cancer patients’ perspectives on financial burden in a universal healthcare system: Analysis of qualitative data from participants from 20 provincial cancer centers in Canada

2020 · Margaret I. Fitch, Christopher J. Longo, et al. · Patient Education and Counseling · 32

PDF

A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care

2007 · Christopher J Longo, Daren K Heyland, et al. · Critical Care · 30

PDF

The Economic Value of a New Insulin Preparation, Humalog?? Mix 25???

2000 · George Dranitsaris, Christopher J. Longo, et al. · PharmacoEconomics · 28

Exploring the impact of out-of-pocket costs on the quality of life of Canadian cancer patients

2018 · Margaret Fitch, Christopher J. Longo · Journal of Psychosocial Oncology · 26

Universal or Targeted Screening for Fetal Alcohol Exposure: A Cost-Effectiveness Analysis

2008 · Robert B Hopkins, Jon Paradis, et al. · Journal of Studies on Alcohol and Drugs · 25

Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer

2017 · R. Martino, J. Ringash, et al. · Current Oncology · 24

PDF

Understanding the full breadth of cancer-related patient costs in Ontario: a qualitative exploration

2016 · Christopher J. Longo, Margaret Fitch, et al. · Supportive Care in Cancer · 21

Linking Intermediate to Final “Real-World” Outcomes: Is Financial Toxicity a Reliable Predictor of Poorer Outcomes in Cancer?

2022 · Christopher J. Longo · Current Oncology · 20

PDF

The transition from youth to adult mental health services and the economic impact on youth and their families

2017 · Neil G. Barr, Christopher J. Longo, et al. · Healthcare Management Forum · 19

Works count: 84

Citation count: 1,893

H-index: 22

I10-index: 36